For use in unrelated donor hematopoietic progenitor cell transplantation procedures in conjunction with an appropriate preparative regimen for hematopoietic & reconstitution in patients with disorders affecting hematopoietic system that are inherited,acquired,or result from myeloablative treatment.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/5OJU8xB
No comments:
Post a Comment